Article 1
Open ↗Alkyl (C 12-16 ) dimethylbenzyl ammonium chloride (ADBAC/BKC (C 12- C 16 )) is approved as an active substance for use in biocidal products of product-type 2, subject to the conditions set out in the Annex.
Commission Implementing Regulation (EU) 2024/235 of 15 January 2024 approving Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-C16)) as an existing active substance for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Alkyl (C 12-16 ) dimethylbenzyl ammonium chloride (ADBAC/BKC (C 12- C 16 )) is approved as an active substance for use in biocidal products of product-type 2, subject to the conditions set out in the Annex.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance ( 1 ) Date of approval Expiry date of approval Product type Specific conditions Alkyl (C 12-16 ) dimethylbenzyl ammonium chloride (ADBAC/BKC (C 12 -C 16 )) IUPAC name: - EC No: 270-325-2 CAS No: 68424-85-1 972 g/kg dry weight 1 July 2025 30 June 2035 2 The authorisation of biocidal products using Alkyl (C 12-16 ) dimethylbenzyl ammonium chloride (ADBAC/BKC (C 12 -C 16 )) as an active substance is subject to the following conditions: (1) the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance; (2) the product assessment shall pay particular attention to professional users. ( 1 ) The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.